The epidemiological findings are due to the requirement that a patient has previously been exposed to platelet-specific antigens before PTP can develop following a subsequent transfusion.

All 78 patients had received RhD-incompatible platelets throughout their engraftment period. Conclusion: Transfusion of RhD-positive blood components to Rh-negative patients with hematologic ...